Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2013 1
2015 3
2016 5
2017 2
2018 1
2019 6
2020 3
2021 5
2022 11
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K. Kaneda-Nakashima K, et al. Among authors: haba h. Int J Mol Sci. 2024 Jan 11;25(2):933. doi: 10.3390/ijms25020933. Int J Mol Sci. 2024. PMID: 38256007 Free PMC article.
Facility upgrade for superheavy-element research at RIKEN.
Sakai H, Haba H, Morimoto K, Sakamoto N. Sakai H, et al. Among authors: haba h. Eur Phys J A Hadron Nucl. 2022;58(12):238. doi: 10.1140/epja/s10050-022-00888-3. Epub 2022 Dec 9. Eur Phys J A Hadron Nucl. 2022. PMID: 36533209 Free PMC article.
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.
Aso A, Nabetani H, Matsuura Y, Kadonaga Y, Shirakami Y, Watabe T, Yoshiya T, Mochizuki M, Ooe K, Kawakami A, Jinno N, Toyoshima A, Haba H, Wang Y, Cardinale J, Giesel FL, Shimoyama A, Kaneda-Nakashima K, Fukase K. Aso A, et al. Among authors: haba h. Int J Mol Sci. 2023 May 12;24(10):8701. doi: 10.3390/ijms24108701. Int J Mol Sci. 2023. PMID: 37240044 Free PMC article.
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.
Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K. Watabe T, et al. Among authors: haba h. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):849-858. doi: 10.1007/s00259-022-06016-z. Epub 2022 Nov 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36344651 Free PMC article.
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.
Watabe T, Kabayama K, Naka S, Yamamoto R, Kaneda K, Serada S, Ooe K, Toyoshima A, Wang Y, Haba H, Kurimoto K, Kobayashi T, Shimosegawa E, Tomiyama N, Fukase K, Naka T. Watabe T, et al. Among authors: haba h. J Nucl Med. 2023 Dec 1;64(12):1949-1955. doi: 10.2967/jnumed.123.266313. J Nucl Med. 2023. PMID: 37827841 Free PMC article.
Stabilization of an 211At-Labeled Antibody with Sodium Ascorbate.
Manabe S, Takashima H, Ohnuki K, Koga Y, Tsumura R, Iwata N, Wang Y, Yokokita T, Komori Y, Usuda S, Mori D, Haba H, Fujii H, Yasunaga M, Matsumura Y. Manabe S, et al. Among authors: haba h. ACS Omega. 2021 May 31;6(23):14887-14895. doi: 10.1021/acsomega.1c00684. eCollection 2021 Jun 15. ACS Omega. 2021. PMID: 34151070 Free PMC article.
44 results